Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.
manilatimes6d
Central Japan Startup Ecosystem Holds Media Event During TechGALA, One of Japan's Largest Startup Events
Participants also visited Nagoya University Startup Laboratory, learning firsthand about what some of the region's most ...